zinc protoporphyrin ix has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, LH; Counter, SA; Ortega, F | 1 |
| Martin, D; McIntosh, TK; Miller, G; Raghupathi, R; Saatman, KE; Sanderson, KL | 1 |
2 other study(ies) available for zinc protoporphyrin ix and Cognition Disorders
| Article | Year |
|---|---|
Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure.
Topics: Adolescent; Case-Control Studies; Child; Cognition; Cognition Disorders; Ecuador; Environmental Exposure; Female; Heme; Humans; Lead; Lead Poisoning, Nervous System, Childhood; Male; Protoporphyrins; Time Factors | 2008 |
Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
Topics: Animals; Antirheumatic Agents; Behavior, Animal; Brain Chemistry; Brain Injuries; Cell Death; Cognition Disorders; Enzyme Inhibitors; Interleukin 1 Receptor Antagonist Protein; Male; Maze Learning; Motor Activity; Neurons; Protoporphyrins; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1; Recombinant Proteins; Sialoglycoproteins | 1999 |